Valencia Technologies, a Valencia, CA-based neuromodulation company focused on minimally invasive treatment of urinary incontinence, announced a strategic investment of up to $35M of committed capital and the appointment of James D. Surek as CEO.
The round was funded by Brooks Advisory Group, an affiliate of Brooks Management Group.
The company intends to use the funds to accelerate the growth of its flagship product, the eCoin® system.
Valencia Technologies is a medical device company that manufactures and markets the eCoin system, a subcutaneous implantable tibial nerve stimulator for UUI. Valencia Technologies received FDA approval for the eCoin system in 2022.
FinSMEs
24/02/2025